课题基金 / 基金详情

Real-world outcomes of proliferative diabetic retinopathy

Real-world outcomes of proliferative diabetic retinopathy
增殖性糖尿病视网膜病变的现实结果
批准号:
10191673
负责人:
Catherine Qing Sun
金额:
$25.22万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-06-01 至 2026-05-31
关键词:
AdultAlgorithmsAnatomyBackground Diabetic RetinopathyBiometryBlindnessCaliforniaCaringClassificationClinicalClinical ResearchClinical Trials DesignClinical effectivenessCodeDataData AnalyticsData SetDatabasesDevelopmentDiabetic RetinopathyDiagnosisDiseaseEffectivenessElectronic Health RecordEnvironmentEthnic OriginEyeEye diseasesFoundational SkillsFoundationsFundingFutureGeneral HospitalsGoalsHealth InsuranceHealthcareHospitalsICD-9ImageInfrastructureInjectionsIntelligenceInterventionKnowledgeLight CoagulationManualsMeasuresMentorsMentorshipMethodsModelingNatural Language ProcessingObservational StudyOphthalmic examination and evaluationOphthalmologistOphthalmologyOutcomeOutcome StudyOutpatientsParticipantPatient RecruitmentsPatientsPerformancePharmaceutical PreparationsPhysicians&apos OfficesPragmatic clinical trialProspective StudiesProviderPublishingRaceRandomized Controlled TrialsRegistriesReportingResearchResearch PersonnelRetrospective StudiesRisk FactorsSan FranciscoStructureSystemTechniquesTestingTextThe SunTimeTrainingTreatment EffectivenessUnited StatesUniversitiesVascular Endothelial Growth FactorsVisionVisualagedbasebiomedical informaticsclinical data warehousecomparison interventioncost effectivenessdesigndiabeticfollow-uphealth disparityhigh riskimprovedimproved outcomeinnovationlow socioeconomic statusmedication compliancenovelpredictive modelingpreventprimary outcomeproliferative diabetic retinopathyrisk stratificationroutine carestructured datatooltreatment as usualunstructured data

项目摘要

项目成果

Catherine Qing Sun的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY: Real-world outcomes of proliferative diabetic retinopathy Vision loss from diabetic retinopathy remains the leading cause of preventable blindness in working-aged adults in the United States (US). Advanced diabetic retinopathy is referred to as proliferative diabetic retinopathy (PDR). In many patients, blindness associated with PDR can be prevented with appropriate and timely diagnosis and treatment. Unfortunately, some patients at high risk for PDR are not receiving adequate eye care. More knowledge is needed about PDR outcomes in a real-world setting, and the differences between published study outcomes and real-world effectiveness. Electronic health records (EHRs) are used in nearly 90% of outpatient physician offices and can be a powerful tool for studying PDR in a real-world setting. The goal of this proposal is to develop and validate EHR-based methods to improve outcomes in PDR. The study aims are: (1) to classify patients with PDR in the EHR system using an automated method that incorporates structured (e.g., diagnosis code, medications, labs) and unstructured data (e.g., clinical notes), (2) to predict the progression of non-proliferative diabetic retinopathy to PDR using a forecasting model with time-varying covariates, and (3) to determine the real-world effectiveness of treatments for PDR in a large nationwide eye dataset. The study will utilize data from the University of California San Francisco’s (UCSF) De-Identified Clinical Data Warehouse, a de-identified EHR with over 1 million patients that has available eye exam information, and the Intelligent Research in Sight (IRIS) registry, a nationwide comprehensive eye database that includes data from over 15,000 eye providers in the US with over 1 million patients with PDR. The innovative methods and tools from this study can be applied to other eye conditions to facilitate future EHR- based clinical studies in ophthalmology. The candidate, Dr. Catherine Sun is an ophthalmologist whose long- term goal is to study real-world clinical outcomes in ophthalmology by conducting EHR-based pragmatic clinical trials and using large-scale EHR data. While she possesses the foundational skills, additional mentored training and coursework in data analytics, biomedical informatics, biostatistics, and advanced clinical trial design and implementation will help her reach her goals. Her outstanding mentorship team of primary mentor Dr. Nisha Acharya and co-mentors Dr. Travis Porco and Dr. Joshua Stein, and the exceptional environment of the Department of Ophthalmology and the F.I. Proctor Foundation at UCSF will support Dr. Sun’s development into an R01-funded independent investigator.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Real-world outcomes of proliferative diabetic retinopathy
Real-world outcomes of proliferative diabetic retinopathy
海外基金